+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Network Point-of-Care Glucose Testing Market Share, Size, Trends, Industry Analysis Report, By Product, By Region, Segment Forecast, 2022 - 2032

  • PDF Icon

    Report

  • 112 Pages
  • July 2023
  • Region: Global
  • Polaris Market Research
  • ID: 5534116
Description Jump to:

Quick Summary:

Within the rapidly evolving landscape of healthcare technology, the Network Point-of-Care (POC) Glucose Testing Market stands out as a dynamic sector ripe with potential. The principle of these POC devices centers on providing swift and accurate blood glucose levels at the point of care, aiding in the timely management of diabetes. An increasing prevalence of this chronic condition forms a significant driving factor behind the industry's expansion.

Decentralized testing marks another essential aspect attributing to the market's growth. It markedly reduces reliance on centralized laboratories, facilitating swift diagnosis and treatment, and easing the strain on comprehensive laboratory services. Advancements in POC glucose testing devices contribute to the expansion of this market, with the advent of technology such as continuous and non-invasive glucose monitoring systems. In essence, the Network POC Glucose Testing Market is on an upward trajectory, presenting myriad opportunities for medical device companies to deliver innovative, cost-effective solutions.

The Global Network Point-of-Care Glucose Testing Market size is expected to reach USD 2,282.04 million by 2032, according to a new study. The report “Network Point-of-Care Glucose Testing Market Share, Size, Trends, Industry Analysis Report, By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, CareSens Expert Plus); By Region; Segment Forecast, 2022 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Network point-of-care (POC) glucose testing refers to using POC devices to measure blood glucose levels at the point of care rather than sending samples to a central laboratory for analysis. These devices are designed to provide fast and accurate results, making them an essential tool for diabetes management.

The network POC glucose testing market is driven by the increasing prevalence of diabetes and the growing demand for decentralized testing. Diabetes is a chronic disease that affects millions of people worldwide and requires regular monitoring of blood glucose levels. The availability of POC glucose testing devices has made it easier for patients to monitor their blood glucose levels at home or in other non-hospital settings. This has improved patient outcomes, as patients can manage their diabetes more effectively with timely and accurate data.

Decentralized testing is another important driver of the network POC glucose testing market. Decentralized testing allows healthcare providers to perform tests at the point of care rather than sending samples to a central laboratory for analysis. This can lead to faster diagnosis and treatment and can help reduce the burden on major laboratory services.

In recent years, there has been a trend towards developing more advanced POC glucose testing devices, such as continuous glucose monitoring systems and non-invasive glucose monitoring devices. These devices offer greater convenience and accuracy and are expected to drive further growth in the network POC glucose testing market.

In conclusion, the network POC glucose testing market is an important and growing segment of the medical device industry. With the increasing prevalence of diabetes and the growing demand for decentralized testing, the market is expected to experience significant growth in the coming years. Medical device companies offering innovative and cost-effective solutions will be well-positioned to capitalize on this growing market.

Global Network Point-of-Care Glucose Testing Market Report Highlights

  • The i-STAT segment of the Global Network Point-of-Care Glucose Testing market is one of the fastest-growing segments of the point-of-care testing (POCT) market. The I-Detail framework is a portable device that provides continuous blood testing and delivers results almost immediately. The system is widely used in emergency rooms, critical care settings, and other point-of-care settings.
  • It is anticipated that the Accu-Chek Inform II segment will have the largest market share in the POCT market. The Accu-Chek Inform II system is a blood glucose monitoring device that provides quick and accurate glucose testing at point-of-care locations. The system is widely used in hospitals, clinics, and physician offices for diabetes management.
  • North America is expected to dominate the global network POC glucose testing market, due to the presence of a well-established healthcare system and high prevalence of diabetes in the region
  • The Asia Pacific region is expected to experience the fastest growth during the forecast period, due to the increasing adoption of POC testing in healthcare facilities, and the rising prevalence of diabetes and other chronic diseases in the region.
  • The global players include F. Hoffmann-La Roche Ltd., Bayer AG/Ascensia Diabetes Care Holdings AG, Nova Biomedical, Abbott, LLC (Lifescan, Inc.), and Danaher.

The publisher has segmented the Global Network Point-of-Care Glucose Testing Market report based on Product, and region:

Global Network Point-of-Care Glucose Testing Market, Product Outlook (Revenue, USD Million, 2019-2032)

  • i-STAT
  • Accu-Chek Inform II
  • StatStrip
  • HemoCue
  • CareSens Expert Plus
  • BAROzen H Expert Plus

Global Network Point-of-Care Glucose Testing Market, Regional Outlook (Revenue - USD Million, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Global Network Point-of-Care Glucose Testing Market

What is the estimated value of the Global Network Point-of-Care Glucose Testing Market?

The Global Network Point-of-Care Glucose Testing Market was estimated to be valued at $1632.77 million in 2023.

What is the growth rate of the Global Network Point-of-Care Glucose Testing Market?

The growth rate of the Global Network Point-of-Care Glucose Testing Market is 3.8%, with an estimated value of $2282.04 million by 2032.

What is the forecasted size of the Global Network Point-of-Care Glucose Testing Market?

The Global Network Point-of-Care Glucose Testing Market is estimated to be worth $2282.04 million by 2032.

Who are the key companies in the Global Network Point-of-Care Glucose Testing Market?

Key companies in the Global Network Point-of-Care Glucose Testing Market include F. Hoffmann, La Roche Ltd., Bayer AG/Ascensia Diabetes Care Holdings AG, Nova Biomedical, Abbott LLC (Lifescan Inc.) and Danaher..
Report AttributeDetails
No. of Pages112
PublishedJuly 2023
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 1632.77 million
Forecasted Market Value ( USD ) by 2032 $ 2282.04 million
Compound Annual Growth Rate3.8%
Regions CoveredGlobal
No. of Companies Mentioned5

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Network Point-of-Care Glucose Testing Market Insights
4.1. Network Point-of-Care Glucose Testing Market - Industry Snapshot
4.2. Network Point-of-Care Glucose Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Introduction of CLIA waived tests
4.2.1.2. Untapped opportunities in the developing economies
4.2.2. Restraints and Challenges
4.2.2.1. Potential interference and calibration issues in glucose meters
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Network Point-of-Care Glucose Testing Industry trends
4.7. COVID-19 Impact Analysis
5. Global Network Point-of-Care Glucose Testing Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
5.3. i-STAT
5.3.1. Global Network Point-of-Care Glucose Testing Market, by i-STAT, by Region, 2019-2032 (USD Million)
5.4. Accu-Chek Inform II
5.4.1. Global Network Point-of-Care Glucose Testing Market, by Accu-Chek Inform II, by Region, 2019-2032 (USD Million)
5.5. StatStrip
5.5.1. Global Network Point-of-Care Glucose Testing Market, by StatStrip, by Region, 2019-2032 (USD Million)
5.6. HemoCue
5.6.1. Global Network Point-of-Care Glucose Testing Market, by HemoCue, by Region, 2019-2032 (USD Million)
5.7. CareSens Expert Plus
5.7.1. Global Network Point-of-Care Glucose Testing Market, by CareSens Expert Plus, by Region, 2019-2032 (USD Million)
5.8. BAROzen H Expert Plus
5.8.1. Global Network Point-of-Care Glucose Testing Market, by BAROzen H Expert Plus, by Region, 2019-2032 (USD Million)
6. Global Network Point-of-Care Glucose Testing Market, by Geography
6.1. Key findings
6.2. Introduction
6.2.1. Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2019-2032 (USD Million)
6.3. Network Point-of-Care Glucose Testing Market - North America
6.3.1. North America: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.3.2. Network Point-of-Care Glucose Testing Market - U.S.
6.3.2.1. U.S.: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.3.3. Network Point-of-Care Glucose Testing Market - Canada
6.3.3.1. Canada: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4. Network Point-of-Care Glucose Testing Market - Europe
6.4.1. Europe: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.2. Network Point-of-Care Glucose Testing Market - UK
6.4.2.1. UK: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.3. Network Point-of-Care Glucose Testing Market - France
6.4.3.1. France: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.4. Network Point-of-Care Glucose Testing Market - Germany
6.4.4.1. Germany: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.5. Network Point-of-Care Glucose Testing Market - Italy
6.4.5.1. Italy: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.6. Network Point-of-Care Glucose Testing Market - Spain
6.4.6.1. Spain: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.7. Network Point-of-Care Glucose Testing Market - Netherlands
6.4.7.1. Netherlands: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.4.8. Network Point-of-Care Glucose Testing Market - Austria
6.4.8.1. Austria: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5. Network Point-of-Care Glucose Testing Market - Asia Pacific
6.5.1. Asia Pacific: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.2. Network Point-of-Care Glucose Testing Market - China
6.5.2.1. China: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.3. Network Point-of-Care Glucose Testing Market - India
6.5.3.1. India: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.4. Network Point-of-Care Glucose Testing Market - Malaysia
6.5.4.1. Malaysia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.5. Network Point-of-Care Glucose Testing Market - Japan
6.5.5.1. Japan: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.6. Network Point-of-Care Glucose Testing Market - Indonesia
6.5.6.1. Indonesia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.5.7. Network Point-of-Care Glucose Testing Market - South Korea
6.5.7.1. South Korea: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.6. Network Point-of-Care Glucose Testing Market - Middle East & Africa
6.6.1. Middle East & Africa: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.6.2. Network Point-of-Care Glucose Testing Market - Saudi Arabia
6.6.2.1. Saudi Arabia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.6.3. Network Point-of-Care Glucose Testing Market - UAE
6.6.3.1. UAE: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.6.4. Network Point-of-Care Glucose Testing Market - Israel
6.6.4.1. Israel: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.6.5. Network Point-of-Care Glucose Testing Market - South Africa
6.6.5.1. South Africa: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.7. Network Point-of-Care Glucose Testing Market - Latin America
6.7.1. Latin America: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.7.2. Network Point-of-Care Glucose Testing Market - Mexico
6.7.2.1. Mexico: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.7.3. Network Point-of-Care Glucose Testing Market - Brazil
6.7.3.1. Brazil: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
6.7.4. Network Point-of-Care Glucose Testing Market - Argentina
6.7.4.1. Argentina: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
7. Competitive Landscape
7.1. Expansion and Acquisition Analysis
7.1.1. Expansion
7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
8.1. F. Hoffmann-La Roche Ltd.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Recent Development
8.2. Bayer AG/Ascensia Diabetes Care Holdings AG
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Recent Development
8.3. Nova Biomedical
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Recent Development
8.4. Abbott, LLC (Lifescan, Inc.
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Recent Development
8.5. Danaher
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Development
List of Tables
Table 1 Global Smart Railway Market, by Product, 2019-2032 (USD Million)
Table 2 Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2019-2032 (USD Million)
Table 3 North America: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 4 U.S.: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 5 Canada: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 6 Canada: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 7 Europe: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 8 Spain: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 9 Netherlands: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 10 Austria: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 11 Germany: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 12 Italy: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 13 France: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 14 Asia Pacific: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 15 China: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 16 Japan: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 17 India: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 18 Indonesia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 19 South Korea: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 20 Malaysia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 21 Latin America: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 22 Brazil: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 23 Mexico: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 24 Argentina: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 25 Middle East & Africa: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 26 South Africa: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 27 Israel: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 28 Saudi Arabia: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
Table 29 UAE: Network Point-of-Care Glucose Testing Market, by Product, 2019-2032 (USD Million)
List of Figures
Figure 1 Global Network Point-of-Care Glucose Testing Market, 2019-2032 (USD Million)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by Product
Figure 7 Global Network Point-of-Care Glucose Testing Market, by Product, 2022 & 2032 (USD Million)
Figure 8 Network Point-of-Care Glucose Testing Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 9 Strategic Analysis - Network Point-of-Care Glucose Testing Market

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • Nova Biomedical
  • Abbott LLC (Lifescan Inc.)
  • Danaher.

Related Topics

Related Reports

Point of Care Diagnostics - Thematic Intelligence - Product Image

Point of Care Diagnostics - Thematic Intelligence

  • Report
  • 34 Pages
  • Global
From
COVID-19 - Competitive Landscape, 2023 - Product Image

COVID-19 - Competitive Landscape, 2023

  • Report
  • 800 Pages
  • Global
From
Global Continuous Glucose Monitoring Systems Market by Component, Demographics, Patient Type, End User, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030 - Product Image

Global Continuous Glucose Monitoring Systems Market by Component, Demographics, Patient Type, End User, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

  • Report
  • 193 Pages
  • Global
From
Point-of-Care Glucose Testing Market By Product Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Point-of-Care Glucose Testing Market By Product Type, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 408 Pages
  • Global
From
Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.